Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
- March -
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
- 2022 -
2023
-
2024
-
2025
March 2022 - 46 products
L
IP
CI
Etoricoxib Viatris 30 mg
28
13.99
31.65
10 %
Coated tablets: Etoricoxibum 30 mg
Viatris Pharma GmbH
● 
B / SL / SG
FB
G
L
IP
Etoricoxib Viatris 60 mg
7
5.55
15.30
10 %
Coated tablets: Etoricoxibum 60 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
Etoricoxib Viatris 60 mg
28
22.21
40.60
10 %
Coated tablets: Etoricoxibum 60 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
Bilaxten 20 mg
10
2.48
4.40
10 %
Melting tablets: Bilastinum 20 mg
A. Menarini GmbH
D / SL / SO
FB
G
IP
CI
Bilaxten 20 mg
30
6.71
11.90
10 %
Melting tablets: Bilastinum 20 mg
A. Menarini GmbH
D / SL / SO
FB
G
IP
CI
Bilaxten 20 mg
50
10.96
19.45
10 %
Melting tablets: Bilastinum 20 mg
A. Menarini GmbH
D / SL / SO
FB
G
IP
CI
Fesoterodin Zentiva 4 mg
14
9.02
26.25
10 %
Delayed release tablets: Fesoterodini Fumaras 4 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Fesoterodin Zentiva 4 mg
84
52.66
73.70
10 %
Delayed release tablets: Fesoterodini Fumaras 4 mg
Helvepharm AG
B / SL / SG
FB
G
IP
Fesoterodin Zentiva 8 mg
14
9.45
26.70
10 %
Delayed release tablets: Fesoterodini Fumaras 8 mg
Helvepharm AG
B / SL / SG
FB
G
IP
Fesoterodin Zentiva 8 mg
84
55.38
76.65
10 %
Delayed release tablets: Fesoterodini Fumaras 8 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Abirateron Zentiva 500 mg
56
897.80
992.05
10 %
Coated tablets: Abirateroni Acetas 500 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban-Mepha 10 mg
14
9.40
19.35
10 %
Coated tablets: Rivaroxabanum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban-Mepha 10 mg
28
18.81
36.95
10 %
Coated tablets: Rivaroxabanum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban-Mepha 10 mg
98
69.13
91.65
10 %
Coated tablets: Rivaroxabanum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Rivaroxaban-Mepha 10 mg
100
70.54
93.10
10 %
Coated tablets: Rivaroxabanum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivaroxaban-Mepha 15 mg
14
9.65
26.90
10 %
Coated tablets: Rivaroxabanum 15 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivaroxaban-Mepha 15 mg
28
18.75
36.80
10 %
Coated tablets: Rivaroxabanum 15 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivaroxaban-Mepha 15 mg
98
69.13
91.60
10 %
Coated tablets: Rivaroxabanum 15 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivaroxaban-Mepha 15 mg
100
70.54
93.05
10 %
Coated tablets: Rivaroxabanum 15 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivaroxaban-Mepha 20 mg
14
9.71
27.00
10 %
Coated tablets: Rivaroxabanum 20 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivaroxaban-Mepha 20 mg
28
18.75
36.80
10 %
Coated tablets: Rivaroxabanum 20 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivaroxaban-Mepha 20 mg
98
69.13
91.60
10 %
Coated tablets: Rivaroxabanum 20 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivaroxaban-Mepha 20 mg
100
70.54
93.05
10 %
Coated tablets: Rivaroxabanum 20 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Sitagliptin Zentiva 25 mg
28
14.08
31.75
10 %
Coated tablets: Sitagliptinum 25 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Sitagliptin Zentiva 25 mg
98
49.25
70.00
10 %
Coated tablets: Sitagliptinum 25 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
Sitagliptin Zentiva 50 mg
28
14.08
31.75
10 %
Coated tablets: Sitagliptinum 50 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
Sitagliptin Zentiva 50 mg
98
49.25
70.00
10 %
Coated tablets: Sitagliptinum 50 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
Sitagliptin Zentiva 100 mg
28
14.08
31.75
10 %
Coated tablets: Sitagliptinum 100 mg
Helvepharm AG
● 
B / SL / SG
FB
G
L
IP
Sitagliptin Zentiva 100 mg
98
49.25
70.00
10 %
Coated tablets: Sitagliptinum 100 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
Fingolimod Devatis 0.5 mg
28
380.52
430.25
10 %
Capsules: Fingolimodum
Devatis AG
B / SL / SG
FB
G
L
IP
Fingolimod Devatis 0.5 mg
98
1331.83
1464.85
10 %
Capsules: Fingolimodum
Devatis AG
B / SL / SG
FB
G
L
IP
CI
SimiMed Ginkgo 240 mg
60
47.45
68.00
10 %
SimiMed AG
B / SL
FB
G
L
IP
CI
SimiMed Ginkgo 240 mg
90
66.90
89.15
10 %
SimiMed AG
B / SL
FB
G
IP
CI
Plegridy 125 mcg/0.5 ml
2
834.66
924.15
10 %
Injektionslösung in einer Fertigspritze zur intramuskulären Anwendung: Peginterferonum Beta-1a 125µg / 0.5ml
Biogen Switzerland AG
B / SL
FB
G
IP
CI
Breyanzi
PR
PR
k.A.
Bristol-Myers Squibb SA
A
FB
G
CI
Similasan überanstrengte
Augen N
20
PR
PR
k.A.
Eye drops: 3 Active Agents
T&S Eye Care
Management AG
D
FB
G
IP
CI
Loperamid-Mepha lingual 2 mg
20
PR
PR
k.A.
Melting tablets: Loperamidi Hydrochloridum 2 mg
Mepha Pharma AG
D
FB
G
IP
CI
Sunosi 75 mg
28
PR
PR
k.A.
Coated tablets: Solriamfetolum 75 mg
Atnahs Pharma
Switzerland AG
B
FB
G
IP
Sunosi 150 mg
28
PR
PR
k.A.
Coated tablets: Solriamfetolum 150 mg
Atnahs Pharma
Switzerland AG
B
FB
G
IP
CI
Fingolimod Devatis 0.25 mg
7
PR
PR
k.A.
Capsules: Fingolimodum
Devatis AG
B
FB
G
IP
CI
Fingolimod Devatis 0.25 mg
28
PR
PR
k.A.
Capsules: Fingolimodum
Devatis AG
B
FB
G
IP
Fingolimod Devatis 0.5 mg
7
PR
PR
k.A.
Capsules: Fingolimodum
Devatis AG
B
FB
G
IP
Fingolimod Devatis 0.5 mg
84
PR
PR
k.A.
Capsules: Fingolimodum
Devatis AG
B
FB
G
CI
Similasan Allergisch
reagierende Augen N
20 x 0.4 ml
PR
PR
k.A.
Augentropfen Monodosen: 3 Active Agents
T&S Eye Care
Management AG
D
FB
G
CI
Similasan Entzündete
Augen N
20 x 0.4 ml
PR
PR
k.A.
Augentropfen Monodosen: 3 Active Agents
T&S Eye Care
Management AG
D
FB
G
CI
Similasan Trockene Augen N
20 x 0.4 ml
PR
PR
k.A.
Augentropfen Monodosen: 3 Active Agents
T&S Eye Care
Management AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home